Skip to main content
SpringerLink
Log in

Protein binding of piretanide in normal and uraemic serum

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The protein binding of piretanide was assessed by continuous ultrafiltration of sera from six normal subjects and seven uraemic subjects (samples taken immediately pre-dialysis). Throughout the range of piretanide concentrations studied (0.5–4.5 mM), the mean protein binding for uraemic serum was less than that for normal serum. This difference was significant (p<0.05) at piretanide concentrations of 1.5 mM and above, but not at 1 mM where mean protein binding for uraemic serum was 88.1% compared to 94.2% for normal serum. Analysis of piretanide protein binding characteristics using the Rosenthal plot showed no significant differences between uraemic and normal serum with respect to primary or secondary binding sites. Parallel assessment by the Scatchard method suggests, as expected, that albumin is the principal protein moiety responsible for binding piretanide.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Merkel W, Bormann D, Mania D, Muschaweck R, Hropot M (1976) Piretanide (HOE 118), a new high ceiling salidiuretic. Eur J Med Chem — Chim Ther 11: 399–406

    Google Scholar 

  2. Roberts CJC, Homeida M, Roberts F, Bogie W (1978) Effects of piretanide, bumetanide and frusemide on electrolyte and urate excretion in normal subjects. Br J Clin Pharmacol 6: 129–133

    Google Scholar 

  3. Lawrence JR, Ansari AF, Elliott HL, Sumner DJ, Brunton GF, Whiting B, Whitesmith R (1978) Kinetic and dynamic comparison of piretanide and furosemide. Clin Pharmacol Ther 23 (5): 558–565

    Google Scholar 

  4. Pozet N, Hadj-Aissa A, Pellet M, Traeger J (1980) Activity of a new high efficiency diuretic in man: piretanide (HOE 118) Br J Clin Pharmacol 9 (6): 577–584

    Google Scholar 

  5. Campion DS, Olsen R (1974) Measurement of drug displacement by continuous ultrafiltration. J Pharmacol Sci 63: 249–252

    Google Scholar 

  6. Rosenthal HE (1967) A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem 20: 525–532

    Google Scholar 

  7. Scatchard G (1949) The attraction of proteins for small molecules and ions. Ann NY Acad Sci 51: 660–692

    Google Scholar 

  8. Forrey AW, Kimpel B, Blair AD, Cutler RE (1974) Furosemide Concentrations in Serum and Urine, and its Binding by Serum Proteins as Measured Fluorimetrically. Clin Chem NY 20: 152–158

    Google Scholar 

  9. Andreasen F, Jacobsen P (1974) Determination of furosemide in blood plasma and its binding to proteins in normal plasma and in plasma from patients with acute renal failure. Acta Pharmacol Toxicol 35: 49–57

    Google Scholar 

  10. Prandotta J, Pruitt AW (1974) Furosemide binding to human albumin and plasma of nephrotic children. Clin Pharm Ther 17: 159–166

    Google Scholar 

  11. Andreasen F, Pedersen OL, Mikkelsen E (1978) Distribution, elimination and natriuretic effect of furosemide in patients with severe arterial hypertension. Eur J Clin Pharmacol 14: 237–244

    Google Scholar 

  12. Rane A, Villeneuve JP, Stone WJ, Nies AS, Wilkinson GR, Branch RA (1978) Plasma binding and disposition of furose-mide in the nephrotic syndrome and in uraemia. Clin Pharmacol Ther 24: 199–207

    Google Scholar 

  13. Boobis SW (1977) Alteration of plasma albumin in relation to decreased drug binding in uraemia. Clin Pharmacol Ther 22 (2): 147–153

    Google Scholar 

  14. Shoemann DW, Azarnoff DL (1972) The alteration of plasma proteins in uraemia as reflected in their ability to bind digitoxin and diphenylhydantoin. Pharmacology 7: 169–177

    Google Scholar 

  15. Reidenberg MM, Odar-Cederlof I, Von Bahr C, Borgå O, Sjöqvist F (1971) Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med 285: 264–267

    Google Scholar 

  16. Andreasen F (1974) The effect of dialysis on the protein binding of drugs in the plasma of patients with acute renal failure. Acta Pharmacol Toxicol 35: 49–57

    Google Scholar 

  17. Campion DS (1973) Decreased drug binding by serum albumin during renal failure. Toxicol Appl Pharmacol 25: 391–397

    Google Scholar 

Download references

Author information

Author notes

  1. J. R. Lawrence

    Present address: Department of Clinical Pharmacology, Hoechst U.K. Ltd., Walton Manor, Milton Keynes, Buckinghamshire, UK

Authors and Affiliations

  1. University Department of Materia Medica, Stobhill General Hospital, Glasgow, Scotland

    H. L. Elliott, A. F. Ansari, B. C. Campbell & J. R. Lawrence

Authors
  1. H. L. Elliott
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. F. Ansari
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. C. Campbell
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J. R. Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Elliott, H.L., Ansari, A.F., Campbell, B.C. et al. Protein binding of piretanide in normal and uraemic serum. Eur J Clin Pharmacol 21, 311–313 (1982). https://doi.org/10.1007/BF00637619

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637619

Key words

Search

Navigation